Objective Integrated Multimodal Electrophysiological Index for the Quantification of Visceral Pain
Start Date
9/8/2025
Completion Date
2/28/2029
Summary
The objectives of the study are to 1) Conduct telemetric biosignals (EDA, ECG, and EMG) recording in healthy controls and IBS participants experiencing cutaneous and visceral pain; and 2) Validate the OIME index as a biomarker for quantifying pain in IBS participants and its capability to assess the treatment of IBS pain via an ambulatory trial.
Detailed Description
In part 1, data collection for training the OIME model, we will collect autonomic and muscular activities with integrated biosignal device and visceral pain level in both healthy controls and IBS participants. These data will be used to train a machine learning model to produce an objective integrated multimodal electrophysiological (OIME) index. In part 2, the ambulatory trial, we will collect data to validate the OIME index as a biomarker of pain in IBS participants. We will run an ambulatory trial to validate the OIME index as a biomarker to assess the treatment of IBS pain.
Eligibility Criteria
Age Range: 18 years to 50 years
Interventions
IBS-PPSM intervention
Conditions
Locations
Vernon Cottage, Depot Campus
Storrs, Connecticut 06269
United States